Inclusion Criteria:~* A Telephone Interview for Cognitive Status - modified (TICS-M) score reflective of intact
cognitive functioning.~* Has a phosphorylated tau (P-tau) result consistent with the presence of amyloid and
early-tau pathology.~* Has a reliable study partner and backup study partner familiar with overall function and
behavior, such as day-to-day activities and cognitive abilities.~* Have adequate literacy, vision, and hearing
for neuropsychological testing at screening.~* Contraceptive use by men or women should be consistent with
local regulations regarding the methods of contraception for those participating in clinical studies~* Female
participants include those who are infertile due to surgical sterilization (hysterectomy, bilateral
oophorectomy, or tubal ligation), congenital anomaly such as Mullerian agenesis; or post menopausal (women 55
or older not on hormone therapy and had at least 12 months of spontaneous amenorrhea; or with a diagnosis of
menopause prior to starting hormone replacement therapy.~
